Ratio of neutrophil/lymphocyte and platelet/lymphocyte in patient with ankylosing spondylitis that are treating with anti-TNF

Basit Öğe Kaydı
dc.authorid0000-0003-2221-4731en_US
dc.authorid0000-0002-0839-7546en_US
dc.contributor.authorBoyraz, İsmail
dc.contributor.authorKoç, Bünyamin
dc.contributor.authorBoyacı, Ahmet
dc.contributor.authorTutoğlu, Ahmet
dc.contributor.authorSarman, Hakan
dc.contributor.authorÖzkan, Hilal
dc.date.accessioned2021-06-23T19:36:38Z
dc.date.available2021-06-23T19:36:38Z
dc.date.issued2014
dc.departmentBAİBÜ, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümüen_US
dc.description.abstractAnkylosing spondylitis (AS) is a type of chronic inflammatory arthritis resulting in ankylosis of the spine and inflammation in the tendons. After NSAIDs, the use of anti-TNF medications has provided a significant contribution to the treatment of patients with AS. The present study was a retrospective, controlled and multicenter study. A total of 105 patients followed in the outpatient clinics of the Department of Physical Therapy in Abant Izzet Baysal University and Harran University and 50 healthy controls were included in the study. The patients had been receiving anti-TNF therapy at least for 6 months. Hemogram results of the patient and control groups examined retrospectively. There was no significant difference between the groups in terms of N/L ratio; however, the P/L ratio was significantly different between the two groups. The present study found a significantly different P/L ratio in patients with AS when compared to the control group. However, the N/L ratio was not significantly different between the groups. The P/L ratio can be used as a marker to monitor disease progression and indicate subclinical inflammation in patients with AS.en_US
dc.identifier.endpage2915en_US
dc.identifier.issn1940-5901
dc.identifier.issue9en_US
dc.identifier.pmid25356158en_US
dc.identifier.scopus2-s2.0-84907829263en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage2912en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4211808/pdf/ijcem0007-2912.pdf
dc.identifier.urihttps://hdl.handle.net/20.500.12491/8030
dc.identifier.volume7en_US
dc.identifier.wosWOS:000345121000067en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorBoyraz, İsmail
dc.institutionauthorKoç, Bünyamin
dc.institutionauthorSarman, Hakan
dc.institutionauthorÖzkan, Hilal
dc.language.isoenen_US
dc.publisherE-Century Publishing Corpen_US
dc.relation.ispartofInternational Journal Of Clinical And Experimental Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAnkylosing Spondylitisen_US
dc.subjectInflammationen_US
dc.subjectNeutrophilen_US
dc.subjectMarkeren_US
dc.titleRatio of neutrophil/lymphocyte and platelet/lymphocyte in patient with ankylosing spondylitis that are treating with anti-TNFen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
ismail-boyraz.pdf
Boyut:
196.83 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam metin/Full text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
Cerrahi Tıp Bilimleri Bölümü Koleksiyonu
Fizyoterapi ve Rehabilitasyon Bölümü Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu